NFKB1 and acute respiratory distress syndrome: These compounds exert therapeutic effects against ALI through multiple mechanisms, including inhibition of classical inflammatory pathways (e.g., NF-κB and MAPK signaling), suppression of neutrophil infiltration, promotion of macrophage polarization toward anti-inflammatory phenotypes, and upregulation of tight junction proteins to maintain epithelial barrier integrity [42].